STERIS plc (STE)
Market Cap | 18.83B |
Revenue (ttm) | 4.78B |
Net Income (ttm) | -27.93M |
Shares Out | 99.28M |
EPS (ttm) | -0.30 |
PE Ratio | n/a |
Forward PE | 23.26 |
Dividend | $1.84 (0.97%) |
Ex-Dividend Date | Feb 23, 2023 |
Volume | 37,781 |
Open | 189.32 |
Previous Close | 187.46 |
Day's Range | 188.78 - 190.11 |
52-Week Range | 159.21 - 255.93 |
Beta | 0.85 |
Analysts | Buy |
Price Target | 224.40 (+18.27%) |
Earnings Date | May 9, 2023 |
About STE
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in th... [Read more]
Financial Performance
In 2022, Steris's revenue was $4.59 billion, an increase of 47.55% compared to the previous year's $3.11 billion. Earnings were $243.89 million, a decrease of -38.63%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for STE stock is "Buy." The 12-month stock price forecast is $224.4, which is an increase of 18.27% from the latest price.
News

STERIS (STE) Q3 Earnings Miss Estimates, Margins Down Y/Y
Negative foreign currency and the impact of increased supply chain and inflationary costs hurt STERIS (STE) revenues in the fiscal third quarter.

Steris (STE) Lags Q3 Earnings and Revenue Estimates
Steris (STE) delivered earnings and revenue surprises of -9.01% and 4.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

STERIS Announces Financial Results for Fiscal 2023 Third Quarter
DUBLIN, IRELAND, Feb. 08, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 third quarter ended December 31, 2022. Reve...

STERIS Declares $0.47 per share Dividend
DUBLIN, IRELAND, Feb. 01, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share....

STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023
DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter finan...

Here's Why Investors Should Retain STERIS (STE) Stock for Now
Investors are optimistic about STERIS (STE), led by strong segmental growth and the Cantel Medical acquisition.

STERIS (STE) Gains on New Orders, FX Impact Dents Growth
STERIS (STE) is on track to achieve its stated goal of approximately $50 million of cost synergies in fiscal 2023.

STERIS (STE) Q2 Earnings Miss Estimates, Margins Increase
Barring AST, poor reported revenue performance across three of STERIS' (STE) operating segments poses concerns.

Steris (STE) Q2 Earnings and Revenues Miss Estimates
Steris (STE) delivered earnings and revenue surprises of -0.50% and 1.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

STERIS Announces Financial Results for Fiscal 2023 Second Quarter
DUBLIN, IRELAND, Nov. 09, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 second quarter ended September 30, 2022. Re...

STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022
DUBLIN, IRELAND, Oct. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 second quarter fina...

What's Driving The Growth For STERIS Stock?
STERIS stock (NYSE: STE), a healthcare company focused on infection prevention, has seen a 29% fall this year, slightly underperforming the broader S&P500 index, down 21%.

Steris (STE) Down 0.8% Since Last Earnings Report: Can It Rebound?
Steris (STE) reported earnings 30 days ago. What's next for the stock?

STERIS (STE) Gains From Cantel Buyout, Supply Chain Issue Stays
Revenue growth at STERIS' (STE) Applied Sterilization Technologies is driven by increased demand from medical device and biopharma customers.

STERIS (STE) Q1 Earnings Match Estimates, EPS View Down
STERIS' (STE) revenues at AST improve driven by increased demand from medical device and biopharma customers.

Steris (STE) Meets Q1 Earnings Estimates
Steris (STE) delivered earnings and revenue surprises of 0% and 5.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

STERIS Announces Financial Results for Fiscal 2023 First Quarter
DUBLIN, IRELAND, Aug. 02, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 first quarter ended June 30, 2022. Revenue ...

STERIS Raises Dividend to $0.47 per share
DUBLIN, IRELAND, July 28, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share....

3 MedTech Stocks That are Likely to Beat This Earnings Season
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how STE, TMO and IDXX are poised ahead of their earnings releases.

Steris (STE) Earnings Expected to Grow: Should You Buy?
Steris (STE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

STERIS to Host a Conference Call for Fiscal 2023 First Quarter Financial Results on August 3, 2022
DUBLIN, IRELAND, July 20, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 first quarter finan...

How Much Upside is Left in Steris (STE)? Wall Street Analysts Think 29%
The mean of analysts' price targets for Steris (STE) points to a 29.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts i...

3 Reasons Why Steris (STE) Is a Great Growth Stock
Steris (STE) possesses solid growth attributes, which could help it handily outperform the market.

Steris (STE) Up 1.5% Since Last Earnings Report: Can It Continue?
Steris (STE) reported earnings 30 days ago. What's next for the stock?

Here's Why You Should Hold STERIS (STE) Stock in Your Portfolio
Investors are optimistic about STERIS (STE) due to its strong fiscal fourth-quarter results.